Screener
Eligibility screening
A Study of Zidesamtinib (NVL-520)
20 US sites in CA, CO, DC, FL +12
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
A Study of Zidesamtinib (NVL-520)
20 US sites in CA, CO, DC, FL +12
Before we begin
Your answer affects how the questions are phrased.